Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer-1

<p><b>Copyright information:</b></p><p>Taken from "Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer"</p><p>http://breast-cancer-research.com/content/9/6/R89</p><p>Breast Cancer Research : BCR 2007;9(6):R89-R89.</p><p>Published online 20 Dec 2007</p><p>PMCID:PMC2246192.</p><p></p>expression. Stratifying patients by nuclear FIH-1 expression. Stratifying patients by exclusive nuclear FIH-1 expression (functional), and by exclusive cytoplasmic FIH-1 expression and FIH-1 negativity (nonfunctional). Stratifying patients by exclusive cytoplasmic FIH-1 expression (nonfunctional), and by exclusive nuclear FIH-1 expression (functional). Stratifying patients by exclusive cytoplasmic FIH-1 expression and tumours negative for FIH-1

Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer-0

<p><b>Copyright information:</b></p><p>Taken from "Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer"</p><p>http://breast-cancer-research.com/content/9/6/R89</p><p>Breast Cancer Research : BCR 2007;9(6):R89-R89.</p><p>Published online 20 Dec 2007</p><p>PMCID:PMC2246192.</p><p></p